Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person12
Rezolute, Inc.
Company
Rezera Inc.
Company
REED'S, INC.
Company
RESMED INC
Company
Reddit, Inc.
Company
REVVITY, INC.
Company
RXO, Inc.
Company
RPC INC
Company
RELIANCE, INC.
Company
RenovoRx, Inc.
Company
REALLOYS INC.
Company
NNN REIT, INC.
Company
Primary record12
Rezolute, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, Rezolute, Inc. issued a press release announcing its financial results for the first quarter ended September 30, 2026. A copy of this press re
Rezolute, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. Rezolute, Inc. (the “ Company ”) prepared presentation materials (the “ Investor Presentation ”) that management released on its website on October 29, 2026. From time to time thereaft
JENNISON ASSOCIATES LLC filed SCHEDULE 13G
0000053417-26-000065.txt : 20261028 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0000053417 XXXXXXXX LIVE Common Stock 09/30/2026 0001509261 REZOLUTE INC 76200L309 275 Shoreline Drive, Suite 500 Redwood City CA 9406
Rezolute, Inc. filed 4
SEC form 4 filed by Rezolute, Inc. (CIK 1509261) on 2026-10-23.
Rezolute, Inc. filed DEF 14A
SEC form DEF 14A filed by Rezolute, Inc. (CIK 1509261) on 2026-10-21.
Rezolute, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 14, 2026, Rezolute, Inc. (the Company ) issued a press release to announce an update on patient enrollment in the Company s upLIFT study. The information in this Current Rep
Rezolute, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 5, 2026, Rezolute, Inc. (the Company ) issued a press release to announce an update on the Company s ongoing discussions with the FDA regarding the Company s sunRIZE trial a
Rezolute, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On September 24, 2026, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of
Rezolute, Inc. filed 4
SEC form 4 filed by Rezolute, Inc. (CIK 1509261) on 2026-09-03.
BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A
0001172661-26-003436.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001193125-26-225186 0001218710 XXXXXXXX LIVE 1 Common Stock 06/30/2026 0001509261 Rezolute, Inc. 76200L309 275 Shoreline Drive Su
BANK OF AMERICA CORP /DE/ filed SCHEDULE 13G/A
0000070858-26-000432.txt : 20260812 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000070858-26-000071 0000070858 XXXXXXXX LIVE 1 Common Stock 06/30/2026 0001509261 Rezolute, Inc. 76200L309 275 SHORELINE DRIVE, S
Rezolute, Inc. filed SCHEDULE 13G
, as amended, Dellora Investments LP and Mr. Pyun expressly disclaim beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission tha